Pharmaceuticals - Community Register


List of nationally authorised veterinary medicinal products


Product name: Vasotop
Active substance: ramipril
Indication: Dogs.
For treatment of congestive heart failure (according to New York Heart Association (NYHA) classification grade II, III & IV) caused by valvular insufficiency due to chronic degenerative valvular heart disease (endocardiosis) or cardiomyopathy, with or without adjunct therapy with the diuretic furosemide and / or the cardiac glycosides digoxin or methyldigoxin.
For the reduction of elevated systolic blood pressure (between 160 and 230 mm Hg) and the control of associated clinical signs.
Marketing Authorisation Holder: Not applicable

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/04/2010 Referral EMEA/V/A-39/51 (2010)2845 of 27/04/2010